Similar protective effect of ischaemic and ozone oxidative preconditionings in liver ischaemia/reperfusion injury

Pharmacological Research

Volumn 45, Issue 4, 2002, Pages 333-339

  Ajamieh, Hussam ^a   Merino, Nelson ^a   Candelario Jalil, Eduardo ^a   Menéndez, Silvia ^d   Martinez Sanchez, Gregorio ^a   Re, Lamberto ^b   Giuliani, Attilia ^c   Leon, Olga Sonia ^a  

^a UNIVERSITY OF HAVANA   (Cuba)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d NONE

Author keywords

Liver ischaemia reperfusion; Oxidative stress; Ozone

Indexed keywords

5' NUCLEOTIDASE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; MALONALDEHYDE; OZONE; THIOL DERIVATIVE; XANTHINE OXIDASE;

AERATION; AMINOTRANSFERASE BLOOD LEVEL; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART INFARCTION PREVENTION; HISTOLOGY; INFRARED RADIATION; LAPAROTOMY; LIVER; LIVER CELL DAMAGE; LIVER ISCHEMIA; LIVER PROTECTION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0036443981     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.2002.0952     Document Type: Article

References (39)

1. Popper H. Hepatocellular degeneration and death. In: The Liver. Biology and Pathobiology. Arias I, Popper H, Schachter D, Shafritz DA, eds. New York: Raven Press, 1982: 771-8.
2. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischaemia: A delay of lethal cell injury in ischaemic myocardium. Circulation 1986; 74: 1124-36.
3. Hotter G, Closa D, Prados M, Fernández-Cruz L, Prats N, Gelpí E, Roselló-Catafau J. Intestinal preconditioning is mediated by a transient increase in nitric oxide. Biochim Biophys Res Commun 1996; 222: 27-32.
4. Swenney MI. Neuroprotective effects of adenosine in cerebral ischaemia: window of opportunity. Neurosci Biobehav Rev 1997; 21: 207-17.
5. Peralta C, Hotter G, Closa D, Gelpí E, Bulbuena O, Roselló-Catafau J. Protective effect of preconditioning on the injury associated to hepatic ischaemia-reperfusion in the rat: Role of nitric oxide and adenosine. Hepatology 1997; 25: 934-7.
6. Atalla SL, Toledo-Pereyra LH, Mackenzie GH, Cederna JP. Influence of oxygen-derived free radical scavengers on ischaemia livers. Transplantation 1985; 40: 584-90.
7. Mathews WR, Guido DM, Fisher MA, Jaeschke H. Lipid peroxidation as molecular mechanism of liver cell injury during reperfusion after ischaemia. Free Rad Biol Med 1994; 16: 763-70.
8. Tan S, Yokoyama Y, Dickens E, Clash TG, Freeman BA, Parks DA. Xanthine oxidase activity in the circulation of rats following hemorrhagic shock. Free Rad Biol Med 1993; 15: 407-14.
9. Yokoyama Y, Beckman JS, Beckman TK, Wheat JK, Cash TG, Freeman BA, Parks DA. Circulating xanthine oxidase: Potential mediator of ischaemic injury. Am J Physiol 1990; 258: G564-70.
10. Granger DN, Rutili G, McCord JM. Superoxide radicals in feline intestinal ischaemia. Gastroenterology 1981; 81: 22-9.
11. Cutrin JC, Cíngaro B. Ischaemic preconditioning protects the rat liver to oxidative stress damage and neutrophil infiltration. In: 50th Annual Meeting & Postgraduate Courses. Hepatology. 1999: vol 30: 227A.
12. Peralta C, Closa D, Hotter G, Gelpí E, Prats N, Roselló-Catafau J. Liver ischaemic preconditioning is mediated by the inhibitory action of nitric oxide on endothelin. Biochem Biophys Res Commun 1996; 229: 264-70.
13. Peralta C, Closa D, Xaus C, Gelpí E, Roselló-Catafau J, Hotter G. Hepatic preconditioning on rats is defined by a balance of adenosine and xanthine. Hepatology 1998; 28: 768-73.
14. Romero A, Menéndez S, Gómez M, Ley J. Ozone therapy in the advanced stages of arteriosclerosis obliterans. Angiologia 1993; 45: 146-8.
15. Menendez S, Iglesias O, Bidot C, Puga R, Carballo A. Application of ozone therapy on children with humoral immunity deficiency. In: Proceedings of 12th Ozone world Congress. Ozone in Medicine.International ozone association Lille: 1995: 271-4.
16. Hernandez F, Menendez S, Wong R. Decrease of blood cholesterol and stimulation of antioxidative response on cardiopathy patients treated with endovenous ozone therapy. Free Rad Biol Med 1995; 19: 115-9.
17. Plopper CG, Duan X, Buckpitt AR, Pinkerton KE. Dose-dependent tolerance to ozone. IV. Site specific elevation in antioxidant enzymes in the lungs of rats exposed for 90 days or 20 months. Toxicol Appl Pharmacol 1994; 127: 124-31.
18. León OS, Menendez S, Merino N, Castillo R, Sam S, Pérez L, Cruz E, Bocci V. Ozone oxidative preconditioning: Protection against cellular damage by free radicals. Mediators Inflamm 1998; 7: 289-94.
19. Barber E, Menéndez S, León OS, Barber MO, Merino N, Calunga JL, Cruz E, Bocci V. Prevention of renal injury after induction of ozone tolerance on rats submitted to warm ischaemia. Mediators Inflamm 1999; 8: 37-41.
20. Peralta C, León OS, Xaus C, Prats N, Jalil EC, Planell ES, Puig-Parellada P, Gelpí E, Roselló-Catafau J. Protective effect of ozone treatment on the injury associated with hepatic ischaemia-reperfusion: Antioxidant-prooxidant balance. Free Rad Res 1999; 31: 191-6.
21. Peralta C, Xaus C, Bartrons R, León OS, Gelpí E, Roselló-Catafau J. Effect of ozone treatment on reactive oxygen species and adenosine production during hepatic ischaemia-reperfusion. Free Rad Res 2000; 33: 595-605.
22. Mohamed Al-Dalain S, Martínez G, Candelario-Jalil E, Menéndez S, Re L, Giuliani A, León OS. Ozone treatment reduces markers of oxidative and endothelial damage in an experimental diabetes model on rats. Pharmacol Res 44: 391-6.
23. Cighetti G, Debiasi S, Paroni R. No documentable role for xanthine oxidase in the pathogenesis of hepatic in vivo ischaemia/reperfusion injury. Pharmacol Res 1994; 3: 243-50.
24. Sedlak J, Lidsay RH. Estimation of total protein bound and non-sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1969; 25: 192-205.
25. Yoshida K, Yamasaki Y, Kawashima S. Calpain activity alters in rat myocardial subfarctions after ischaemia or reperfusion. Biochim Biophys Acta 1993; 1182: 215-20.
26. Van Winkle DM, Downey JM, Thornton JD, Davis RF. Ischaemic preconditioning on myocardium: effect of adenosine. In: Recent Advances in Coronary Circulation. Maruyama et al., ed. Tokyo: Springer, 1993: 223-34.
27. Peralta C, Rull R, Rimola A, Deulofeu R, Catafau-Roselló J, Gelpí E, Rodes J. Endogenous nitric oxide and exogenous nitric oxide supplementation in hepatic ischaemia-reperfusion injury on the rat. Transplantation 2001; 71: 529-36.
28. Lindert KA, Calwell-Kendel JC, Nukina S, Leemasters JJ, Thurman RG. Activation of Kupffer cells on reperfusion following hypoxia: Particle phagocytosis in a low-flow, reflow model. Am J Physiol 1992; 262: G345-50.
29. Nakamitsu A, Hiyama E, Imamura Y, Matsuura Y, Yokoyama Y. Kupffer cell function in ischemic and nonischemic livers after hepatic partial ischemia/reperfusion. Surg Today 2001; 31: 140-8.
30. Caldwell-Kenkel JC, Currin RT, Tanaka Y, Thurman RG, Lemasters JJ. Kupffer cell activation and endothelial cell damage after storage of rat livers: Effect of reperfusion. Hepatology 1991; 13: 83-95.
31. Adkinson D, Hollwarth ME, Benoit JN, Parks DA, McCord JM, Granger DN. Role of free radicals in ischaemia-reperfusion injury to the liver. Acta Physiol Scand 1986; Suppl 548: 101-7.
32. Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischaemia/reperfusion injury on rat liver in vivo. FASEB J 1990; 4: 3355-9.
33. Parks DA, Granger DN. Xanthine oxidase: Biochemistry, distribution and physiology. Acta Physiol Scand 1986; 548: 87-99.
34. Abraham W, Vance G, Sidharta T, Simon G, Sadis M, Kelly A, Bradley E, Dale A. Liver ischaemia-reperfusion increases pulmonary permeability in rat: Role of circulating xanthine oxidase. Am J Physiol 1995; 268: G988-96.
35. Hamer I, Wattiaux R, Wattiaux-De Coninck S. Deleterious effects of xanthine oxidase on rat liver endothelial cells after ischaemia/reperfusion. Biochim Biophys Acta 1995; 1269: 145-52.
36. Saksela M, Lapatto R, Raivio KO. Irreversible conversion of xanthine dehydrogenase into xanthine oxidase by a mitochondrial protease. FEBS Lett 1999; 443: 117-20.
37. Pryor WA, Church DF. Aldehydes, hydrogen peroxide, and organic radicals as mediators of ozone toxicity. Free Rad Biol Med 1991; 11: 41-6.
38. Esterbauer H, Shaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad Biol Med 1991; 11: 81-128.
39. Hamilton RF, Li L, Eschenbacher WL, Szweda L, Holian A. Potential involvement of 4-hydroxynonenal in the response of human lung cells to ozone. Am J Physiol 1998; 274: L8-16.